Ownership
Private
Stage
Other
Preclinical
Phase 1
Phase 2
Phase 3
Approved

BioNJ General Information

BioNJ serves as New Jersey’s leading life sciences trade association, representing over 400 member organizations including research-based life sciences companies, academic institutions, patient advocacy groups, and service providers. It advocates for public policy favorable to the industry, provides networking and educational opportunities, supports workforce development through job boards and career services, and promotes health equity in clinical trials. Its mission centers on supporting innovation in biopharmaceutical research and ensuring patient access to new therapies[1][4][5][6]. "As New Jersey’s life sciences trade association, BioNJ represents over 400 Member Companies who are research-based life sciences companies and stakeholders...committed to the growth and prosperity of the State’s vibrant ecosystem where Science is Supported...and Patients are Paramount."[4] "BioNJ is dedicated to ensuring the State’s innovation ecosystem continues to innovate the life-saving and groundbreaking therapies that have been researched and developed right here in the Garden State."[6] The organization also operates purchasing consortia for cost savings among members[3], runs events for networking/education[1], maintains a career portal[7], advocates at state/federal levels[5][6], supports health equity initiatives[1], connects innovators with capital/investors[3], and works closely with policymakers. It does not itself conduct R&D or commercialize products but plays a central role in supporting those who do.

Contact Information

Primary Industry
Consulting
Corporate Office
Trenton area or central NJ, New Jersey
United States

Drug Pipeline

No pipeline data available

For full access to BioNJ's pipeline data

Book a demo

Key Partnerships

Works closely with major pharmaceutical/biotech firms based or operating in New Jersey as members, collaborates with academic institutions, partners on policy initiatives but has no formal joint ventures typical of commercial entities

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

BioNJ Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view BioNJ's complete valuation and funding history, request access »

BioNJ Financial Metrics